| |
Welcome to the Bulimia
File
Patients all over the world
have used the information in The Bulimia File since 1992, when
the Center for Current Researchone of the first 80 companies
on the Internetwas founded. Our highly trained researchers
(all of whom hold Ph.D.s) have searched the advanced medical
database at the National Library of Medicine and compiled a comprehensive
collection of research descriptions on Bulimia and its care.
As you will see, the following research descriptions detail the
findings published in the most respected journals in the field.
Because the research descriptions are written in medical terms,
most people will bring all or parts of the Bulimia File to their
doctor for further explanation and discussion. Often your doctor
will have access to full-text articles and other information
that could be useful in planning a successful course of treatment
and prevention. Note that the titles of the journals are abbreviated
according to the National Library of Medicine's format; your
doctor can provide the full title if you need it.
Thank you for accessing the Bulimia File. We truly hope the information
fosters better health.
Sincerely,
Gregory A. Fraser, Ph.D.
Director of Research
Important Note: The following information
is provided for your education. It should not be relied upon for
personal diagnosis or treatment. If you believe that a
particular therapy applies to you or someone you care about, be
sure to consult a doctor before trying it.
On Downloading (Please Read
Carefully)
To
download or print the Bulimia
File, point your mouse to "File" in the top bar of your Explorer
or Netscape window, and click once. Now click once on either "Save As"
(download), or "Print" (print), and follow the appropriate
prompts.
Latest Research on Bulimia
Eat Disord. 2008 Jan-Feb;16(1):52-72.
Experiences of women with bulimia nervosa in a mindfulness-based
eating disorder treatment group.
Proulx K.
University of Massachusetts, Amherst, Massachusetts, USA.
The experience of 6 college-age women with bulimia nervosa was examined after
they participated in an 8-week mindfulness-based eating disorder treatment
group. This phenomenological study used individual interview and pre- and
post-treatment self-portraits. Participants described their experience of
transformation from emotional and behavioral extremes, disembodiment, and
self-loathing to the cultivation of an inner connection with themselves
resulting in greater self-awareness, acceptance, and compassion. They reported
less emotional distress and improved abilities to manage stress. This treatment
may help the 40% of women who do not improve with current therapies and might be
useful to prevent symptoms in younger women.
-------
Eat Disord. 2008 Jan-Feb;16(1):30-9.
Parental psychopathology as a predictor of
long-term outcome in bulimia nervosa patients.
Arikian A, Keel PK, Miller KB, Thuras P, Mitchell JE, Crow SJ.
Department of Psychiatry, University of Minnesota, Minneapolis,
Minnesota, USA.
This paper sought to examine parental variables as predictors of
long-term outcome in women with bulimia nervosa (BN).
Participants were 94 treatment-seeking women with BN who were
assessed at baseline, treatment end, and at follow-up (M=10.13
years). Participants reported rates of psychopathology and
obesity in their mothers and fathers at baseline. The most
frequently reported parental psychopathology was substance abuse
in fathers. Chi-square analyses indicated that substance abuse
in fathers was associated with poor treatment-end outcome in BN
participants. Depression in mothers was associated with poor
outcome at long-term follow-up, and obesity in mothers was
associated with better outcome at long-term follow-up. A
logistic regression analysis found that lifetime mood disorder
in participants and severe depression in mothers were
independent predictors of bulimic symptoms at long-term
follow-up. The association between maternal severe depression
and long-term outcome in BN suggests that specific parental
variables may indicate longer course of BN.
-----
Psychother Psychosom. 2008;77(1):57-60. Epub 2007 Dec 14.
Repetitive transcranial magnetic stimulation in
bulimia nervosa: preliminary results of a single-centre,
randomised, double-blind, sham-controlled trial in female
outpatients.
Walpoth M, Hoertnagl C, Mangweth-Matzek B, Kemmler G,
Hinterhölzl J, Conca A, Hausmann A.
Department of General Psychiatry, Innsbruck Medical University,
Innsbruck, Austria. Michaela.Walpoth@i-med.ac.at
BACKGROUND: Bulimia nervosa (BN) is often associated with
depressive symptoms and treatment with antidepressants has shown
positive effects. A shared deficient serotonergic transmission
was postulated for both syndromes. The left dorsolateral
prefrontal cortex was argued to regulate eating behaviour and to
be dysfunctional in eating disorders. METHODS: Fourteen women
meeting DSM-IV criteria for BN were included in a randomised
placebo-controlled double-blind trial. In order to exclude
patients highly responsive to placebo, all patients were first
submitted to a one-week sham treatment. Randomisation was
followed by 3 weeks of active treatment or sham stimulation. As
the main outcome criterion we defined the change in binges and
purges. Secondary outcome variables were the decrease of the
Hamilton Depression Rating Scale (HDRS), the Beck Depression
Inventory (BDI) and the Yale-Brown Obsessive Compulsive Scale (YBOCS)
over time. RESULTS: The average number of binges per day
declined significantly between baseline and the end of treatment
in the two groups. There was no significant difference between
sham and active stimulation in terms of purge behaviour, BDI,
HDRS and YBOCS over time. CONCLUSION: These preliminary results
indicate that repetitive transcranial magnetic stimulation (rTMS)
in the treatment of BN does not exert additional benefit over
placebo. A larger number of patients might clarify a further
role of rTMS in the treatment of BN. 2008 S. Karger AG, Basel
-----
Int J Eat Disord. 2007 Nov 20 [Epub ahead of print]
Eating disorder symptoms in pregnancy: A
prospective study.
Crow SJ, Agras WS, Crosby R, Halmi K, Mitchell JE.
Department of Psychiatry, University of Minnesota Medical
School, Minneapolis, Minnesota.
Previous work suggests that eating disorder symptoms diminish
with pregnancy. However, little prospective study has been
conducted, and little is known about pregnancy symptoms in
eating disorder not otherwise specified.OBJECTIVE:: To
prospectively study both eating behaviors and disordered eating
cognitions in pregnant women with various eating disorder
diagnoses. METHOD:: Forty-two participants became pregnant
during 4-year follow-up of 385 women with full or subthreshold
anorexia nervosa, bulimia nervosa, or binge eating disorder.
Participants completed the Eating Disorders Examination (EDE) at
6-month intervals. Mixed modeling procedures were used to
examine change in eating disorder cognitions, binge eating, and
purging. RESULTS:: EDE restraint, EDE shape concerns, EDE weight
concerns, binge eating, and purging diminished from prepartum to
intrapartum, but returned to approximately baseline levels
postpartum. CONCLUSION:: In this longitudinal sample of women
with diverse
eating disorder diagnoses, eating disorder symptoms improved
during pregnancy, but worsened postpartum. These results
highlight pregnancy as a potential time for eating disorder
interventions. (c) 2007 by Wiley Periodicals, Inc. Int J Eat
Disord 2007.
-----
Int J Eat Disord. 2007 Oct 5 [Epub ahead of print]
A critical evaluation of the efficacy of
self-help interventions for the treatment of bulimia nervosa and
binge-eating disorder.
Sysko R, Walsh BT.
Department of Psychiatry, College of Physicians and Surgeons of
Columbia University, New York, New York.
OBJECTIVE:: Cognitive behavioral therapy (CBT) is efficacious
for the treatment of bulimia nervosa (BN) and binge-eating
disorder (BED). As a number of factors limit the availability of
CBT, self-help manuals have been developed to make the treatment
more widely available. METHOD:: Published studies evaluating the
efficacy of self-help programs in the treatment of BN and BED
were reviewed. RESULTS:: Controlled studies of self-help
programs for BN and BED have often employed a waiting list
control group, and indicate that self-help provides more benefit
than remaining on a waiting list. However, fewer studies have
utilized a more active control group, and these studies have not
been as positive. CONCLUSION:: In general, open and wait-list
trials indicate that self-help is helpful in treating BN and
BED, but there is little evidence for the specific efficacy of
self-help in comparison to other treatments. Additional studies
of self-help are needed to determine the specific utility of
self-help interventions for BN and BED. (c) 2007 by Wiley
Periodicals, Inc. Int J Eat Disord 2007.
-----
Aust Fam Physician. 2007 Sep;36(9):708-12, 731.
Understanding bulimia.
Hay PJ.
Discipline of Psychiatry, School of Medicine, James Cook
University, Townsville, and The Institute of Psychiatry, The
Townsville Hospital, New South Wales, Australia. p.hay@uws.edu.au
BACKGROUND: Bulimia nervosa (BN) and related eating disorders
such as binge eating disorder are common. General practitioners
can play a key role in the identification and management of BN
and related eating disorders. OBJECTIVE: This article describes
the presenting and associated features of BN and overviews
evidence based treatment approaches. DISCUSSION: Key features
are recurrent episodes of binge eating, extreme weight control
behaviours and over concern about weight and shape issues. By
definition people are not underweight. Risk factors include
being from a western culture, obesity, exposure to a restrictive
dieting environment and low self esteem. People are more likely
to present asking for help in weight control or a physical
problem secondary to the eating disorder. Evidenced based
therapies with good outcomes in current use are cognitive
behaviour therapy (in full or guided self help forms), high dose
fluoxetine, and interpersonal psychotherapy. It is important t
o convey optimism about treatment efficacy and outcomes.
-----
J Clin Psychiatry. 2007 Sep;68(9):1324-32.
Double-blind, randomized, placebo-controlled
trial of topiramate plus cognitive-behavior therapy in
binge-eating disorder.
Claudino AM, de Oliveira IR, Appolinario JC, Cordás TA, Duchesne
M, Sichieri R, Bacaltchuk J.
Department of Psychiatry, Universidade Federal de São Paulo,
Brazil. angelica@psiquiatria.epm.br
OBJECTIVE: To evaluate the efficacy and tolerability of
adjunctive topiramate compared to placebo in reducing weight and
binge eating in obese patients with binge-eating disorder (BED)
receiving cognitive-behavior therapy (CBT). METHOD: A
double-blind, randomized, placebo-controlled trial of 21 weeks'
duration was conducted at 4 university centers. Participants
were 73 obese (body mass index >or= 30 kg/m(2)) outpatients with
BED (DSM-IV criteria), both genders, and aged from 18 to 60
years. After a 2- to 5-week run-in period, selected participants
were treated with group CBT (19 sessions) and topiramate (target
daily dose, 200 mg) or placebo (September 2003-April 2005). The
main outcome measure was weight change, and secondary outcome
measures were binge frequencies, binge remission, Binge Eating
Scale (BES) scores, and Beck Depression Inventory (BDI) scores.
RESULTS: Repeated-measures random regression analysis revealed a
greater rate of weight reduction associated with topiramate over
the course of treatment (p < .001), with patients taking
topiramate attaining a clinically significant weight loss (-6.8
kg) compared to patients taking placebo (-0.9 kg). Although
rates of reduction of binge frequencies, BES scores, and BDI
scores did not differ between groups during treatment, a greater
number of patients of the topiramate plus CBT group (31/37)
attained binge remission compared to patients taking placebo
(22/36) during the trial (p = .03). No difference between groups
was found in completion rates; 1 patient (topiramate group)
withdrew for adverse effect. Paresthesia and taste perversion
were more frequent with topiramate, and insomnia was more
frequent with placebo (p < .05). CONCLUSIONS: Topiramate added
to CBT improved the efficacy of the later, increasing binge
remission and weight loss in the short run. Topiramate was well
tolerated, as shown by few adverse events during treatment.
CLINICAL TRIALS REGISTRATION: ClinicalTrials.gov identifier
NCT00307619.
-----
Eur Eat Disord Rev. 2007 Sep 18 [Epub ahead of print]
Getting better byte by byte: a pilot randomised
controlled trial of email therapy for bulimia nervosa and binge
eating disorder.
Robinson P, Serfaty M.
Russell Unit, Barnet Enfield and Haringey Mental Health Trust,
UK.
One hundred and ten people in an university population responded
to emailed eating disorder questionnaires. Ninty-seven
fulfilling criteria for eating disorders (bulimia nervosa (BN),
binge eating disorder (BED), EDNOS) were randomised to therapist
administered email bulimia therapy (eBT), unsupported Self
directed writing (SDW) or Waiting list control (WLC). Measures
were repeated at 3 months. Diagnosis, Beck depression inventory
(BDI) and Bulimia investigatory test (BITE) scores were
recorded. Follow-up rate was 63% and results must be interpreted
cautiously. However significantly fewer participants who had
received eBT or SDW fulfilled criteria for eating disorders at
follow up compared to WLC. There was no significant difference
between eBT and SDW in the analysis of variance (ANOVA),
although in separate analyses, eBT was significantly superior to
WLC (p < 0.02) and the difference for SDW approached
significance (p = 0.06). BDI and BITE scores showed no
significant change. For eBT participants there was a significant
positive correlation between words written and improvement in
BITE severity score. BN, BED and EDNOS can be treated via email.
Copyright (c) 2007 John Wiley & Sons, Ltd and Eating Disorders
Association.
-----
Expert Opin Pharmacother. 2007 Sep;8(13):2029-44.
Eating disorders: an overview of treatment responses and the
potential impact of vulnerability genes and endophenotypes.
Ramoz N, Versini A, Gorwood P.
1INSERM U675, Université Paris 7, IFR02, Faculté de Médecine Xavier Bichat,
Paris, France.
Anorexia nervosa (AN), bulimia nervosa (BN) and binge-eating disorder (BED) are
the three main eating disorders. Antidepressants, antipsychotics,
anticonvulsants, prokinetic agents, opiate antagonists, appetite suppressants,
tetrahydrocannabinol, cyproheptadine, zinc and ondansetron have been tested, and
are frequently associated with psychological treatment. Selective serotonin
reuptake inhibitors have a proven efficacy in BN and binge eating disorder.
Other treatments, such as atypical antipsychotics in AN, anticonvulsants in BN
and BED, and naltrexone and ondansetron in BN, may be promising, but lack the
appropriate trials. The development of genetic researches in eating disorders
may help the clinician to choose the most appropriate treatment in forthcoming
years, using genetic polymorphisms of vulnerability genes, those linked to
endophenotypes, or genes implicated in the metabolism of the drug treatment.
-----
Eur Eat Disord Rev. 2007 Sep;15(5):357-65.
Which elements in the treatment of eating disorders are necessary
'ingredients' in the recovery process?—A comparison between the patient's and
therapist's view.
Vanderlinden J, Buis H, Pieters G, Probst M.
University Center St-Jozef, Kortenberg, Belgium. johan.vanderlinden@uc-kortenberg.be
BACKGROUND: Little is known about which therapeutic 'ingredients' in the
treatment of eating disorders (anorexia nervosa (AN), bulimia nervosa (BN) and
binge eating disorder (BED)) are needed for recovery. Remarkably, most studies
on this topic have neglected the patient's view. METHOD: In this study, a large
sample of eating disorder patients (n = 132) was invited to evaluate which
elements in the treatment they consider to be helpful and effective in their
recovery process. These results were compared to the view of 49 eating disorder
experts. RESULTS: Following the patient's view, 'improving self-esteem',
'improving body experience' and 'learning problem solving skills', were
considered as core elements in their treatment. No major differences were found
between the different patient samples when comparing the patient's and
therapist's view. DISCUSSION: The findings suggest that therapists and patients
share more or less the same view about the basic and effective elements in the
treatment. 2006 John Wiley & Sons, Ltd and Eating Disorders Association
-----
Eur Eat Disord Rev. 2007 Aug 28; [Epub ahead of print]
Symptom severity and treatment course of bulimic patients with
and without a borderline personality disorder.
Zeeck A, Birindelli E, Sandholz A, Joos A, Herzog T, Hartmann A.
Department of Psychosomatic Medicine and Psychotherapy, University of Freiburg,
Germany.
There are contradictory results concerning the frequency of borderline
personality disorder (BPD) in bulimic patients and its impact on eating
pathology and treatment outcome. We evaluated 240 patients with bulimia nervosa
using EDI-2, SIAB and SCL-90-R. Only a minority of patients had a BPD (13.8%).
There were no differences in binging or purging behaviour between patients with
and without BPD, but borderline patients had significantly more feelings of
ineffectiveness and more disturbances in interoceptive awareness. Bulimic
patients with BPD showed significantly more general psychopathology. Although,
BPD patients started with higher levels of pathology, there were similar
reductions of symptoms over the course of treatment in both groups.
Psychotherapy in bulimic patients with a BPD has to focus not only on eating
pathology but also on aspects that are caused by the severe personality
disturbance. Copyright (c) 2007 John Wiley & Sons, Ltd and Eating Disorders
Association.
-----
Aust Fam Physician. 2007 Aug;36(8):614-9.
Eating disorders in adolescents.
Gonzalez A, Kohn MR, Clarke SD.
Centre for Research into Adolescents' Health (CRASH), Department of Adoelscent
Medicine, Westmead Hospital, New South Wales, Australia.
BACKGROUND: The overall prevalence of eating disorders among children and
adolescents is rising - the younger age group are more likely to present with
anorexia nervosa (AN), while the older adolescent can present with either AN or
bulimia nervosa (BN). However, eating disorders exist as part of a spectrum and
general practitioners will encounter many adolescents that have an eating
disorder that do not yet fulfil diagnostic criteria for either AN or BN.
OBJECTIVE: This article aims to provide an overview of assessment and principles
of management of eating disorders in the adolescent patient. DISCUSSION: General
practitioners are key in recognising and offering early intervention in cases of
incipient eating disorders or problem dieting behaviour. The physical findings
of AN are those of protein calorie malnutrition, while in BN, they reflect
chronic purging. Failure of outpatient management requires hospitalisation for
nutritional rehabilitation with close monitoring of fluid and electrolyte status
to prevent the development of refeeding syndrome. Family involvement is vital,
particularly in the younger patient, with ongoing family therapy offering the
best outcomes.
-----
Int J Eat Disord. 2007 Jul 2; [Epub ahead of print]
Cue exposure in the treatment of resistant adolescent bulimia
nervosa.
Martinez-Mallén E, Castro-Fornieles J, Lázaro L, Moreno E, Morer A, Font E,
Julien J, Vila M, Toro J.
Department of Child and Adolescent Psychiatry and Psychology, Institute Clinic
of Neurosciences, Hospital Clínic Universitari of Barcelona, Barcelona, Spain.
OBJECTIVE:: A percentage of bulimic patients do not greatly improve with the
usual treatment. Therefore, the objective was to further evaluate cue exposure
(CE), in order to attain better results in clinical settings. METHOD::
Twenty-two adolescent patients who fulfilled DSM-IV diagnostic criteria for
bulimia nervosa (mean age 16.7, SD 1.5) and who were resistant to the usual
treatment followed a program of 12 CE sessions. Clinical characteristics were
evaluated and different psychopathological scales were administered at the
beginning and the end of the CE program and at 6 month follow-up. Subjective
anxiety and physiological parameters were recorded during the sessions.
RESULTS:: A significant decrease was observed in subjective anxiety (p = .023),
heart rate (p < .001), and blood pressure (p = .001) during the first session. A
decrease in these parameters was also recorded between the first and the last
session. The number of binges per week (p = .005) and the mean score for the
psychopathological scales decreased significantly from the beginning of the
treatment, and were significantly lower at the end of the CE program and at
follow-up. Purging behaviors per week only decreased significantly after the end
of the CE session during the follow-up (p = .04). CONCLUSION:: Anxiety,
bingeing, purging, and psychopathological scales improve with a CE program in
resistant bulimia nervosa. (c) 2007 by Wiley Periodicals, Inc. Int J Eat Disord
2007.
-----
Evid Rep Technol Assess (Full Rep). 2006 Apr;(135):1-166.
Management of eating disorders.
Berkman ND, Bulik CM, Brownley KA, Lohr KN, Sedway JA, Rooks A, Gartlehner G.
OBJECTIVES: The RTI International-University of North Carolina at Chapel Hill
Evidence-based Practice Center (RTI-UNC EPC) systematically reviewed evidence on
efficacy of treatment for anorexia nervosa (AN), bulimia nervosa (BN), and binge
eating disorder (BED), harms associated with treatments, factors associated with
the treatment efficacy and with outcomes of these conditions, and whether
treatment and outcomes for these conditions differ by sociodemographic
characteristics. DATA SOURCES: We searched MEDLINE(R), the Cumulative Index to
Nursing and Applied Health (CINAHL), PSYCHINFO, the Educational Resources
Information Center (ERIC), the National Agricultural Library (AGRICOLA), and
Cochrane Collaboration libraries. REVIEW METHODS: We reviewed each study against
a priori inclusion/exclusion criteria. For included articles, a primary reviewer
abstracted data directly into evidence tables; a second senior reviewer
confirmed accuracy. We included studies published from 1980 to September 2005,
in all languages. Studies had to involve populations diagnosed primarily with
AN, BN, or BED and report on eating, psychiatric or psychological, or biomarker
outcomes. RESULTS: We report on 30 treatment studies for AN, 47 for BN, 25 for
BED, and 34 outcome studies for AN, 13 for BN, 7 addressing both AN and BN, and
3 for BED. The AN literature on medications was sparse and inconclusive. Some
forms of family therapy are efficacious in treating adolescents. Cognitive
behavioral therapy (CBT) may reduce relapse risk for adults after weight
restoration. For BN, fluoxetine (60 mg/day) reduces core bulimic symptoms (binge
eating and purging) and associated psychological features in the short term.
Individual or group CBT decreases core behavioral symptoms and psychological
features in both the short and long term. How best to treat individuals who do
not respond to CBT or fluoxetine remains unknown. In BED, individual or group
CBT reduces binge eating and improves abstinence rates for up to 4 months after
treatment; however, CBT is not associated with weight loss. Medications may play
a role in treating BED patients. Further research addressing how best to achieve
both abstinence from binge eating and weight loss in overweight patients is
needed. Higher levels of depression and compulsivity were associated with poorer
outcomes in AN; higher mortality was associated with concurrent alcohol and
substance use disorders. Only depression was consistently associated with poorer
outcomes in BN; BN was not associated with an increased risk of death. Because
of sparse data, we could reach no conclusions concerning BED outcomes. No or
only weak evidence addresses treatment or outcomes difference for these
disorders. CONCLUSIONS: The literature regarding treatment efficacy and outcomes
for AN, BN, and BED is of highly variable quality. In future studies,
researchers must attend to issues of statistical power, research design,
standardized outcome measures, and sophistication and appropriateness of
statistical methodology.
-----
Presse Med. 2007 Apr 2; [Epub ahead of print]
[Nasogastric tube feeding in bulimia.]
[Article in French]
Rigaud D, Brayer V, Biton-Jelic V, Pais V, Pennacchio H, Brun JM.
CHU Le Bocage, Dijon (21).
OBJECTIVE: Few effective treatments are available for severe forms of bulimia
nervosa, which are accompanied by malnutrition, anxiety, and depressive mood. We
previously showed in an open study that nasogastric tube feeding (TF) reduced
binges and purging in patients with anorexia nervosa. METHODS: This prospective
randomized trial compared bulimia patients in two treatment groups: one group
received TF at home, together with psychotherapy, nutritional counseling and a
support group while the control group received only psychotherapy, nutritional
counseling, and a support group. Patients in the first group underwent TF for 8
weeks (exclusively for 10 days and associated with meals thereafter). Assessment
was based on clinical examination, laboratory results, and a variety of
questionnaires (our in-house instrument for measuring binge and vomiting
episodes, eating disorder inventory, Beck's depression inventory and the
Hamilton rating scale for anxiety), all performed at the onset of treatment and
at 8days, 8 weeks (i.e., the end of TF), and 3 months after treatment began.
RESULTS: Binges and vomiting disappeared faster and more frequently in TF
patients than in the control group: 65% versus 29% (p<0.01). Three months later,
these remained less frequent in the TF group than among controls (52% versus
33%, p=0.064). Nutritional status, depression, and anxiety improved more among
the TF than control subjects (p<0.05). CONCLUSION: Tube feeding was effective in
these patients with bulimia nervosa, reducing the number of binge and vomiting
episodes and improving nutritional status and mood.
-----
Am J Psychiatry. 2007 Apr;164(4):591-8.
A randomized controlled trial of family therapy and cognitive
behavior therapy guided self-care for adolescents with bulimia nervosa and
related disorders.
Schmidt U, Lee S, Beecham J, Perkins S, Treasure J, Yi I, Winn S, Robinson P,
Murphy R, Keville S, Johnson-Sabine E, Jenkins M, Frost S, Dodge L, Berelowitz
M, Eisler I.
Section of Eating Disorders (PO59), Institute of Psychiatry, De Crespigny Park,
Denmark Hill, London SE5 8AF, UK. u.schmidt@iop.kcl.ac.uk.
OBJECTIVE: To date no trial has focused on the treatment of adolescents with
bulimia nervosa. The aim of this study was to compare the efficacy and
cost-effectiveness of family therapy and cognitive behavior therapy (CBT) guided
self-care in adolescents with bulimia nervosa or eating disorder not otherwise
specified. METHOD: Eighty-five adolescents with bulimia nervosa or eating
disorder not otherwise specified were recruited from eating disorder services in
the United Kingdom. Participants were randomly assigned to family therapy for
bulimia nervosa or individual CBT guided self-care supported by a health
professional. The primary outcome measures were abstinence from binge-eating and
vomiting, as assessed by interview at end of treatment (6 months) and again at
12 months. Secondary outcome measures included other bulimic symptoms and cost
of care. RESULTS: Of the 85 study participants, 41 were assigned to family
therapy and 44 to CBT guided self-care. At 6 months, bingeing had undergone a
significantly greater reduction in the guided self-care group than in the family
therapy group; however, this difference disappeared at 12 months. There were no
other differences between groups in behavioral or attitudinal eating disorder
symptoms. The direct cost of treatment was lower for guided self-care than for
family therapy. The two treatments did not differ in other cost categories.
CONCLUSIONS: Compared with family therapy, CBT guided self-care has the slight
advantage of offering a more rapid reduction of bingeing, lower cost, and
greater acceptability for adolescents with bulimia or eating disorder not
otherwise specified.
-----
Psychother Psychosom Med Psychol. 2007 Mar-Apr;57(3-4):120-7.
[Body images of male patients with eating disorders.]
[Article in German]
Benninghoven D, Tadic V, Kunzendorf S, Jantschek G.
Klinik fur Psychosomatische Medizin und Psychotherapie, Universitatsklinikum
Schleswig-Holstein, Campus Lubeck.
Ideals of male attractiveness have changed considerably. The ideal male body at
present is characterized by low body fat and pronounced muscles. Similar to what
has been found for women, these normative societal conceptions should influence
the pathology of men with eating disorders. In the present study, men with and
without eating disorders are compared regarding body satisfaction and body
perception. Both questionnaire data and a computer assisted approach are
applied. Men with bulimia nervosa wish to have a body with less fat whereas men
with anorexia do not wish for a bigger body although they are seriously
underweight. Men in all groups wish to have more muscles. Men with and without
an eating disorder do not differ in this respect. The wish for less body fat and
more muscles is associated with body dissatisfaction in men. Treatment of men
with eating disorders should focus on men's body images similar to how it is
conceptualized in treatments for women with eating disorders. Different from
women, a body image focused approach for men should emphasize the meaning of
muscularity.
-----
Compr Psychiatry. 2007 Mar-Apr;48(2):118-23. Epub 2006 Nov 7.
Body image in patients with eating disorders and their mothers,
and the role of family functioning.
Benninghoven D, Tetsch N, Kunzendorf S, Jantschek G.
University of Schleswig-Holstein, Campus Luebeck, Clinic for Psychosomatic
Medicine, 23538 Luebeck, Germany. benningh@medinf.mu-luebeck.de
OBJECTIVE: Little is known about body images of mothers of patients with eating
disorders. In this study we investigated body image in patients with eating
disorders and in their mothers, and the relationship of their body images with
family functioning. METHODS: A computer program was used that allows modeling
perceived and desired body images of patients and their mothers. Patients and
mothers estimated their own body images and mothers estimated the images they
have of their daughters with eating disorders. The selected images were compared
to anthropometric data and family functioning according to the Family Assessment
Measure. Data from 29 patients with the diagnosis of anorexia nervosa and 20
patients with bulimia nervosa are presented. RESULTS: Both in patients with
anorexia and in patients with bulimia, aspects of family functioning were
associated with mothers' and daughters' perceptual body size distortion and body
dissatisfaction. Mothers' perception of family functioning predicted daughters'
perceptual body size distortion and body dissatisfaction in the total sample of
49 patients. CONCLUSION: Body images of mothers and mothers' perceptions of
family functioning may provide additional information for the treatment of
patients with eating disorders.
-----
Prax Kinderpsychol Kinderpsychiatr. 2007;56(2):91-108.
[Dialectical behavior therapy for adolescents with anorexia and
bulimia nervosa (DBT-AN/ BN)—a pilot study]
[Article in German]
Salbach H, Klinkowski N, Pfeiffer E, Lehmkuhl U, Korte A.
Charite-Universitatsmedizin Berlin, Campus Virchow-Klinikum, Klinik fur
Psychiatrie, Psychosomatik und Psychotherapie des Kindes-und Jugendalters,
Berlin. harriet.salbach@charite.de
Dialectical behavior therapy (DBT) was originally developed by Linehan (1993a,
b) and modified by Miller et al. (1997) for suicidal adolescents with borderline
personality features. Meanwhile, this therapy has also successfully applied in
other adult clinical groups. The prior aim of the study is to evaluate the
effectiveness of DBT for inpatient adolescents with anorexia and bulimia
nervosa. In this pilot study (n=31) the efficacy of this treatment will be
evaluated in a pre-post comparison. Different instruments will be used (SIAB,
EDI-2, SCL-90-R, FBB). The first results are promising and we must hope that
this new approach will improve the future treatment.
-----
Int J Eat Disord. 2007 Mar 16; [Epub ahead of print]
Bulimia nervosa treatment: A systematic review of randomized
controlled trials.
Shapiro JR, Berkman ND, Brownley KA, Sedway JA, Lohr KN, Bulik CM.
Department of Psychiatry, University of North Carolina at Chapel Hill, North
Carolina.
OBJECTIVE:: The RTI International-University of North Carolina at Chapel Hill
Evidence-based Practice Center systematically reviewed evidence on efficacy of
treatment for bulimia nervosa (BN), harms associatedwith treatments, factors
associated with treatment efficacy, and differential outcome by sociodemographic
characteristics. METHOD:: We searched six major databases published from 1980 to
September 2005 in all languages against a priori inclusion/exclusion criteria;
we focused on eating, psychiatric or psychological, and biomarker outcomes.
RESULTS:: Forty-seven studies of medication only, behavioral interventions only,
and medication plus behavioral interventions for adults or adolescents met our
inclusion criteria. Fluoxetine (60 mg/day) decreases the core symptoms of binge
eating and purging and associated psychological features in the short term.
Cognitive behavioral therapy reduces core behavioral and psychological features
in the short and long term. CONCLUSION:: Evidence for medication or behavioral
treatment for BN is strong, for self-help is weak; for harms related to
medication is strong but either weak or nonexistent for other interventions; and
evidence for differential outcome by sociodemographic factors is nonexistent.
Attention to sample size, standardization of outcome measures, attrition, and
reporting of abstinence from target behaviors are required. Longer follow-up
intervals, innovative treatments, and attention to sociodemographic factors
would enhance the literature. (c) 2007 by Wiley Periodicals, Inc. Int J Eat
Disord 2007.
-----
Int J Eat Disord. 2007 Mar 8;40(4):360-368 [Epub ahead of print]
The eating disorders medicine cabinet revisited: A clinician's
guide to ipecac and laxatives.
Steffen KJ, Mitchell JE, Roerig JL, Lancaster KL.
Neuropsychiatric Research Institute, Fargo, North Dakota.
OBJECTIVE:: To describe the frequency of alternative medication use in bulimia
nervosa (BN), and to review available nonprescription emetic (ipecac) and
laxative products and their potential toxicities. METHOD:: Survey data were
collected from 39 consecutive treatment-seeking patients with BN or subthreshold
BN. Survey data of the available nonprescription and herbal products from local
retail stores were also collected. Toxicology information was reviewed on these
agents from MEDLINE and herbal textbooks. RESULTS:: Ipecac use occurred in 18%
of the 39 patients. Laxatives had been used at some point to control weight or
"get rid of food" by 67% of the patients. Of these, 31% had abused laxatives
during the month prior to evaluation. In the product survey, 248
laxative-containing products were identified. CONCLUSION:: There are numerous
laxative products readily available to patients, and many of them have
significant associated toxicities. Patients with BN tend to endorse high rates
of laxative use. While ipecac is used infrequently, it can have deleterious
consequences. Patients with BN should be screened for use of both ipecac and
laxatives and should be educated about the potential consequences associated
with the misuse of these agents. (c) 2007 by Wiley Periodicals, Inc. Int J Eat
Disord 2007.
-----
Prax Kinderpsychol Kinderpsychiatr. 2007;56(1):19-39.
[Intensive outpatient group treatment for adolescents with eating
disorders]
[Article in German]
Michler P, Wolter-Flanz A, Linder M.
Klinik fur Kinder - und Jugendsychistrie Psychotherapie, Univeristatsstr,
Regensburg. petra.michler@medbo.de
We present an intensive outpatient group treatment for girls with eating
disorders (anorexia nervosa, bulimia nervosa, binge eating disorder)
additionally to/instead of inpatient treatment or individually treatment by
psychotherapists. The therapy concept is primarily behaviour therapy oriented,
encouraging the self-management-abilities of the patients thereby learning
self-determination and responsibility in dealing with their illness. The
slow-open group concept provokes group cohesion, solidarity and support among
girls, who share similar age-related development-stages and eating disorders.
Other than cognitive behaviour therapy and the principles of self-management we
use client-centered therapy, art-, dance- and nutritional therapy. For each
patient an individual treatment plan is adapted depending on age, individual
symptoms, problems and motivation. Each member of the group has to accept
defined group rules during the group sessions. The group takes place twice a
week and on one Saturday per month. The adolescents stay in their social
environment. Transfer of therapeutic success into daily life therefore is
immediate and longlasting. Duration of therapy is between four months and one
year, longer only in complex cases. Parallel to the parent/patient cooperation a
parental psycho-educative group is available.
-----
J Am Diet Assoc. 2006 Dec;106(12):2073-82.
Position of the American Dietetic Association: Nutrition
intervention in the treatment of anorexia nervosa, bulimia nervosa, and other
eating disorders.
American Dietetic Association.
It is the position of the American Dietetic Association that nutrition
intervention, including nutritional counseling, by a registered dietitian (RD)
is an essential component of the team treatment of patients with anorexia
nervosa, bulimia nervosa, and other eating disorders during assessment and
treatment across the continuum of care. Diagnostic criteria for eating disorders
provide important guidelines for identification and treatment. However, it is
thought that a continuum of disordered eating may exist that ranges from
persistent dieting to subthreshold conditions and then to defined eating
disorders, which include anorexia nervosa, bulimia nervosa, and binge eating
disorder. Understanding the complexities of eating disorders, such as
influencing factors, comorbid illness, medical and psychological complications,
and boundary issues, is critical in the effective treatment of eating disorders.
The nature of eating disorders requires a collaborative approach by an
interdisciplinary team of psychological, nutritional, and medical specialists.
The RD is an integral member of the treatment team and is uniquely qualified to
provide medical nutrition therapy for the normalization of eating patterns and
nutritional status. RDs provide nutritional counseling, recognize clinical signs
related to eating disorders, and assist with medical monitoring while cognizant
of psychotherapy and pharmacotherapy that are cornerstones of eating disorder
treatment. Specialized resources are available for RDs to advance their level of
expertise in the field of eating disorders. Further efforts with evidenced-based
research must continue for improved treatment outcomes related to eating
disorders along with identification of effective primary and secondary
interventions.
-----
Prescrire Int. 2006 Dec;15(86):221.
Fluoxetine. Bulimia nervosa: don't use.
[No authors listed]
In practice, in patients seeking treatment for bulimia nervosa, fluoxetine has
been shown to provide only transient efficacy, and patients are exposed to the
drug's adverse effects. Cognitive and behavioural therapies are better treatment
options.
-----
Bipolar Disord. 2006 Dec;8(6):686-95.
Comorbidity of eating disorders with bipolar disorder and
treatment implications.
McElroy SL, Kotwal R, Keck PE Jr.
Psychopharmacology Research Program, Department of Psychiatry, University of
Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA.
susan.mcelroy@uc.edu
OBJECTIVES: To review the scientific evidence examining the comorbidity among
eating disorders and bipolar disorder (BD). METHODS: We reviewed all published
English-language studies addressing the comorbidity of anorexia nervosa,
bulimia, bulimia nervosa, and binge eating disorder in patients with BD and
studies of comorbidity of BD in patients with eating disorders. In addition, we
discuss the pharmacologic treatment implications from reviewed studies of agents
used in BD and eating disorders. RESULTS: Community and clinical population
studies of the lifetime prevalence rates of eating disorders in patients with
BD, and of BD in patients with eating disorders, particularly when subthreshold
and spectrum manifestations of these disorders are included, indicate high rates
of comorbidity among these illnesses. CONCLUSIONS: Pharmacologic treatment
approaches to patients with BD and a co-occurring eating disorder require
examination of the possible adverse effects of the treatment of each syndrome on
the other and attempts to manage both syndromes with agents that might be
beneficial to both.
-----
Int J Eat Disord. 2006 Nov 1;40(2):95-101 [Epub ahead of print]
Treatment of bulimia nervosa: Where are we and where are we
going?
Mitchell JE, Agras S, Wonderlich S.
Neuropsychiatric Research Institute, Fargo, North Dakota.
OBJECTIVE:: The purpose of this article is to review the extant treatment
literature on bulimia nervosa and to offer suggestions for future research
directions. METHOD:: The available treatment studies regarding both
pharmacotherapy and psychotherapy are reviewed. RESULTS:: Both pharmacotherapy
and psychotherapy appear to play a role in the treatment of bulimia nervosa;
however, available data suggest that cognitive behavioral therapy remains the
treatment of choice. CONCLUSION:: Additional work is clearly indicated regarding
assisted and unassisted self-help. An enhanced form of CBT and the integrative
cognitive-affective therapy both deserve further study. New approaches need to
be piloted. More research is needed on treatment modeling. (c) 2006 by Wiley
Periodicals, Inc. Int J Eat Disord 2006.
-----
Seishin Shinkeigaku Zasshi. 2006;108(7):736-41.
[Intensive psychiatric treatment system for bulimic patients by
group therapy]
[Article in Japanese]
Suzuki K.
Concurrent bulimia nervosa/purging type and anorexia nervosa/binge-purging type
including binge eating and purging behaviors are considered chronic types of
eating disorders. The bulimic patients in this study had both these disorders.
Psychiatric treatment for patients with eating disorders must focus on therapy
of these bulimic patients, because bulimic patients are more prevalent in the
psychiatric hospital and clinic, and they have more comorbid psychiatric
disorders and more other addictive behaviors than other patients with eating
disorders. We have devised an intensive psychiatric treatment system for bulimic
patients by group therapy that consists of inpatient treatment, group therapy
for parents and group rehabilitation. Inpatient treatment, called the Eating
Disorders Education Program (EDEP), consists of group psychological education,
group cognitive-behavioral therapy, group nutrition education, and group
exercise. Group therapy for parents consists of psychological education and
group meetings. Group rehabilitation consists of many group activities in a
house named "Mimoza". Bulimic patients come to understand their own disorders
and symptoms objectively and understand recovery from their disorders by the
intensive treatment system. Bulimic patients generally recover very slowly from
eating disorders, but our intensive psychiatric treatment system promotes rapid
recovery.
-----
Int J Eat Disord. 2006 Nov;39(7):533-43.
Using imagery in cognitive-behavioral treatment for eating
disorders: tackling the restrictive mode.
Mountford V, Waller G.
Eating Disorders Service, South West London and St. George's Mental Health NHS
Trust, London, England. vicki.mountford@swlstg-tr.nhs.uk
A restrictive thinking style in the eating disorders, often referred to as
"anorexic thinking," is often resistant to cognitive-behavioral interventions,
even when apparent motivation is relatively high. It is argued that this
difficulty is due in part to the ingrained nature of such thinking patterns,
regardless of diagnosis. Those patterns reflect the ego-syntonic element of the
eating disorders, and manifest as difficulty for the patient in identifying and
challenging negative automatic thoughts and maladaptive core beliefs. There is a
need to develop cognitive techniques that allow the individual to identify
maladaptive cognitions as reflecting their restrictive schema mode, rather than
being the only way of thinking and seeing the world. This study describes the
use of imagery to enable patients to distinguish the restrictive thoughts from
other cognitive perspectives. The restrictive "mode" is presented as part of the
individual's personality structure (drawing on cognitive-behavioral models of
personality), rather than being an external entity. This technique is designed
to facilitate conventional cognitive-behavioral therapy, freeing the patient to
challenge her cognitions and to engage in behavioral experiments. We present
case material to illustrate this technique and its use in conjunction with other
cognitive-behavioral techniques. Future directions and potential limitations are
also discussed. (c) 2006 by Wiley Periodicals, Inc.
©Copyright 1992-date by The Center
for Current Research. The Bulimia File is a proprietary compilation
of the Center for Current Research. The information in the File
is solely for your use, and the use of your family, friends, and
doctors. The information is the property of the individual researchers
and institutions that produced it. It is an infringement of copyright
law to attempt to "resell" the information as it is
presented here.
|